Which has higher immunization, hib3, Latvia or Sub-Saharan Africa?

Latvia, at 97.0% against 74.0% in Sub-Saharan Africa as of 2024.

How many years of comparable data are there for Latvia and Sub-Saharan Africa?

31 years are reported by both, from 1994 to 2024.

Where does this data come from?

WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Latvia vs Sub-Saharan Africa: Immunization, Hib3

Latvia

97.0%

in 2024

Sub-Saharan Africa

74.0%

in 2024

Latvia rank

29th

Sub-Saharan Africa rank

32nd

Immunization, Hib3 over time

Latvia
Sub-Saharan Africa

How they compare

Latvia currently reports 97.0% against 74.0% in Sub-Saharan Africa, a difference of 23.0%.

That makes Latvia's figure about 1.3 times Sub-Saharan Africa's.

Across all 31 years both countries report, Latvia has been ahead every year.

Latvia ranks 29th and Sub-Saharan Africa ranks 32nd of 191 countries.

Latvia has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade	Latvia	Sub-Saharan Africa	Difference	Ahead
1990s	48.8%	0.1%	48.8%	Latvia
2000s	92.1%	20.8%	71.3%	Latvia
2010s	94.2%	68.4%	25.8%	Latvia
2020s	96.4%	73.4%	23.0%	Latvia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, hib3, Latvia or Sub-Saharan Africa?: Latvia, at 97.0% against 74.0% in Sub-Saharan Africa as of 2024.
What is the difference in immunization, hib3 between Latvia and Sub-Saharan Africa?: 23.0%, with Latvia ahead.
How many years of comparable data are there for Latvia and Sub-Saharan Africa?: 31 years are reported by both, from 1994 to 2024.
How do Latvia and Sub-Saharan Africa rank globally for immunization, hib3?: Latvia ranks 29th and Sub-Saharan Africa ranks 32nd of 191 countries.
Where does this data come from?: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Latvia vs Sub-Saharan Africa: Immunization, Hib3. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 16 September 2026, from https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/latvia/sub-saharan-africa/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/latvia/sub-saharan-africa/">Latvia vs Sub-Saharan Africa: Immunization, Hib3</a> — Statizoid

About this data

Indicator: Immunization, Hib3 (% of children ages 12-23 months)
Unit: % of children ages 12-23 months
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 234 places, 5,441 data points, 1990–2024
Last refreshed: 03 September 2026

Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.